title: Lamivudine enabled isoniazid and rifampicin treatment in pulmonary tuberculosis and hepatitis B co-infection.
authors.forename: Wai Cho
authors.initials: WC
authors.lastname: Yu
authors.forename: Sik To
authors.initials: ST
authors.lastname: Lai
authors.forename: Ming Chee
authors.initials: MC
authors.lastname: Chiu
authors.forename: Tai Nin
authors.initials: TN
authors.lastname: Chau
authors.forename: Tak Keung
authors.initials: TK
authors.lastname: Ng
authors.forename: Cheuk Ming
authors.initials: CM
authors.lastname: Tam
mesh_terms: D000995:Antitubercular Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006509:Hepatitis B / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage / Q000627:therapeutic use*; D019259:Lamivudine / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D012293:Rifampin / Q000008:administration & dosage / Q000627:therapeutic use*; D014397:Tuberculosis, Pulmonary / Q000150:complications / Q000188:drug therapy*
chemical_list: D000995:Antitubercular Agents; D000998:Antiviral Agents; D019259:Lamivudine; D007538:Isoniazid; D012293:Rifampin